Participation in a Research Registry for Immune Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

716 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-09-30

Study Completion Date

2023-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has a network to collect data about people with PIDD. It is called the United States Immunodeficiency Network. It will help doctors and scientists better understand these disorders. The goal is to get medical data for everyone with these disorders in the U.S. and Canada. Data will be stored in a registry. Researchers can use it to study if these disorders are increasing. They can also learn how the disorders are diagnosed and treated.

Objectives:

\- To collect data on people with primary immune deficiency disorders.

Eligibility:

\- People who have a PIDD.

Design:

* Data can be added with no record of personal identity.
* Data can be added with identity kept separate. This data will be linked to the registry by a code number.
* Data for the registry includes:
* Family history
* Disease treatment
* Disease characteristics
* Medical history
* Laboratory data

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland

NCT01150240

Primary Immunodeficiency Disease

UNKNOWN

Detection and Characterization of Host Defense Defects

NCT00001355

Immune Defects

RECRUITING

Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms

NCT00015431

Common Variable Immunodeficiency

COMPLETED

Intensive Care Unit and Secondary and Primary Immune Deficiency

NCT02888535

Primary Immune Deficiency Disorder

COMPLETED

Evaluation of Patients With Immune Function Abnormalities

NCT00128973

Chronic Granulomatous Disease (CGD) X-Linked Severe Combined Immune Deficiency (XSCID) Leukocyte Adhesion Deficiency 1 (LAD) +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this protocol is to provide a resource for clinical and laboratory research through enrollment of known immunodeficiency patients into a national registry, the US Immunodeficiency Network (USIDNET). The registry data will expand NIH s and the nation s knowledge base about immune deficiency disorders and genetic mutations that lead to these disorders. Additional registrants from NIH protocols will not only increase the understanding of the molecular basis of these disorders, but also will serve to document and track the incidence and progression of complications.

Objectives and specific aims

The purpose of this proposal is to create a mechanism for depositing NIH data into USIDNET. The patient Registry is designed to obtain longitudinal data on a large number of patients with primary immunodeficiency diseases, and genetic carriers of these defects in order to:

* Learn more about the phenotypic variations seen in a large number of individual patients with the same rare molecular diagnosis.
* Determine the natural history of these genetic disorders of immunity and establish genotype-phenotype correlations.
* Learn effects of various treatment protocols used in these patients over time, including unexpected side effects that may be unique to a particular diagnostic group.
* To evaluate quality of life using standard tools and correlate these with genotype and treatment history.
* To promote collaborative research amongst interested investigators by identifying a larger pool of potential research subjects than would be available at their own institutions
* To identify patients with a specific diagnosis for potential participation in multi-institutional clinical trials designed for diagnosis or therapy or their specific disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Immunodeficiencies APECED CGD Wiskott-Aldrich Syndrome SCID

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

immunodeficiency

Individuals of all ages, gender, and races with an immunodeficiency disorder from NIH studies, will be accepted for registration.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Individuals of all ages, gender, and races with an immunodeficiency disorder from NIH studies will be accepted for registration. No healthy volunteers will be enrolled.

Exclusion Criteria

Individuals with immunodeficiency associated with HIV infection, chemotherapy or other immunosuppressive therapies will not be accepted for registration unless there is clear evidence that these individuals also have a genetically determined immunodeficiency disease as well. Adult individuals who do not give informed consent will also be excluded.

Minimum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

No